SpurMeUp
Les Howe
Looks interesting. Not sure how it works...
Sitting on my porcelain throne using glory-glory.co.uk mobile app
I'm interested in both sides of the dealLooks interesting. Not sure how it works...
Sitting on my porcelain throne using glory-glory.co.uk mobile app
I'm interested in both sides of the deal
Looks interesting. Not sure how it works...
Sitting on my porcelain throne using glory-glory.co.uk mobile app
Had to invest some cash to avoid pay tax. Why are we taxed so highly in the UK?
@danish picked up that Lemonade insurer, as well as Rox or something a similar service. Didn’t put much into them, pretty risky bet as it’s unclear if the US public will embrace them. But with their valuations significantly down both represent fair value.
Also risky I bought quite a lot of GoodXR. A drug dealing app that helps yanks save money. Again down significantly (because Amazon will enter their space). But their downloads, head start, and integration with doctors is promising so put in 13k. Could very easily double in value...or half! High risk stocks. Will either retire well off or broke [emoji23]
Sitting on my porcelain throne using glory-glory.co.uk mobile app
I do wonder whether the Americans will force amazon to break up.
I doubt it. But it is turning into a global monolith. There is no competing with it. It's ingrained. And it pays barely any tax. More likely that they get these tech companies paying fair amounts of tax.
I didn't do my research yesterday morning and was rushing to invest while the market was down. Read for about 15 mins, then pressed the button on the shares above. Then really researched them in the afternoon. Have some regrets with GoodXR. Its not flavour of the month, and I wasn't aware of its PE ratio, and cost of sales (how much they spend to generate a customer) being so high (excuse the pun). But I'm in now. I almost sold it right away on the same day! One thing made me hold it - the genuine App reviews...the Apps underlying fundamentals are sound. People love it. In the US it saves people $50 a week. It has a loyal user base who pay for the Gold membership and it saves its users lots of money. But Amazon getting in...or the US government reforming the way drugs are priced may scupper their model. That won't happen tomorrow, so I'll stick with it as drug dealing makes money. And yanks love their drugs! We should start a substance thread. Anyone tried DMT? It lasts only 20 mins or so, but is supposed to be the most profound trip:
I doubt it. But it is turning into a global monolith. There is no competing with it. It's ingrained. And it pays barely any tax. More likely that they get these tech companies paying fair amounts of tax.
I didn't do my research yesterday morning and was rushing to invest while the market was down. Read for about 15 mins, then pressed the button on the shares above. Then really researched them in the afternoon. Have some regrets with GoodXR. Its not flavour of the month, and I wasn't aware of its PE ratio, and cost of sales (how much they spend to generate a customer) being so high (excuse the pun). But I'm in now. I almost sold it right away on the same day! One thing made me hold it - the genuine App reviews...the Apps underlying fundamentals are sound. People love it. In the US it saves people $50 a week. It has a loyal user base who pay for the Gold membership and it saves its users lots of money. But Amazon getting in...or the US government reforming the way drugs are priced may scupper their model. That won't happen tomorrow, so I'll stick with it as drug dealing makes money. And yanks love their drugs! We should start a substance thread. Anyone tried DMT? It lasts only 20 mins or so, but is supposed to be the most profound trip:
I blame all these trading apps, makes trading too easy. I bet all the trading plaforms make a killing out of people buying then selling again within a week when the price hasn't shot up.
That's good advice @SpurMeUp.Yes its too easy. And these Apps hide the fees so effectively. Moral of the story is do the research. The best research isn't news articles (though they are important). Once the piece has been written the knowledge is outdated. The best insights are things you experience or see with companies directly, or people in companies you talk to who can give you first-hand info on demand etc. Rising demand that you can see and make a logic for before the masses do; ideally backed up by standard things like a low PE ratio, analysts insights etc. is optimal.
I think GoodXR will come good. As the US opens up, people will be getting to the doctors and needing more drugs. So will hold and find out.
Freetrade price doing well.
Have you a link to their price? I didn’t know they’d floated.
No it is on the resale market for members.